AlzeCure’s drug for Alzheimer’s shows positive effect in Phase I trial

AlzeCure Pharma has reported latest findings from the Phase I clinical trial where its drug candidate, ACD856, showed to offer a positive effect on brain activity in Alzheimer’s disease.